Filter
1424
Filtered Results: 1424
Text search:
Ministry
of
Health,
Department
of
Drug
Administration
Featured
Recommendations
128
New Publications
500
Language
Document type
No document type
956
Guidelines
183
Studies & Reports
164
Manuals
55
Strategic & Response Plan
45
Training Material
14
Situation Updates
4
Fact sheets
3
Countries / Regions
India
124
Kenya
79
Ethiopia
53
Nigeria
50
Uganda
49
Tanzania
44
Myanmar / Burma
43
Liberia
41
Nepal
39
Ghana
36
Zambia
36
Western and Central Europe
32
Sierra Leone
28
Malawi
28
Rwanda
24
Bangladesh
23
Global
23
Latin America and the Carribbean
22
Eastern Europe
18
Ukraine
17
Africa
17
Namibia
15
Zimbabwe
14
Botswana
13
Cambodia
12
South Africa
10
Lesotho
10
South–East Asia Region
10
Mozambique
9
Eswatini/ Swaziland
8
Indonesia
7
Philippines
6
South Sudan
6
Asia
6
Tajikistan
6
Senegal
5
Cameroon
5
Thailand
5
East and Southern Africa
5
Russia
5
Georgia
5
Congo, Democratic Republic of
4
Pakistan
4
Jordan
4
Syria
4
Sudan
4
Middle East and North Africa
4
Paraguay
4
Albania
4
Laos
4
Burkina Faso
3
Haiti
3
Germany
3
China
3
Eastern Europe and Central Asia
3
Sri Lanka
2
West and Central Africa
2
Poland
2
Timor Leste/ East Timor
2
Iran
2
Mali
1
Morocco
1
Saudi Arabia
1
Somalia
1
Iraq
1
Afghanistan
1
Lebanon
1
Turkey
1
Gambia
1
Singapore
1
Papua New Guinea
1
Benin
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Serbia
1
Hungary
1
Colombia
1
Bolivia
1
Greece
1
Libya
1
Angola
1
Madagascar
1
Western Pacific Region
1
Fiji
1
Bhutan
1
Venezuela
1
Palestine
1
Qatar
1
Estonia
1
Romania
1
Moldova
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
788
Clinical Guidelines
122
Public Health
58
Women & Child Health
47
Key Resources
33
Pharmacy & Technologies
16
Capacity Building
12
Toolboxes
TB
111
HIV
108
Mental Health
84
AMR
68
Pharmacy
56
NTDs
50
COVID-19
41
Rapid Response
38
Caregiver
30
Ebola
17
Refugee
13
Conflict
12
Planetary Health
11
NCDs
10
Disability
8
Global Health Education
7
Natural Hazards
5
Specific Hazards
5
Cholera
4
Polio
4
Health Financing Toolbox
4
Zika
3
Social Ethics
3
Health Financing
1
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of... those 13 products is the neonatal resuscitator, is indispensable medical device to save newborns from asphyxia at birth. For the efficient use of neonatal resuscitation, training of healthcare professionals using neonatal resuscitation manikins is the most effective approach. Critical lifesaving trainings calls for the need of neonatal resuscitation manikins with the right features.
The purpose of the WHO Neonatal resuscitation manikin: technical specifications is to provide a minimum standard baseline to meet the increasing demand to procure good quality, affordable, accessible, and appropriate neonatal resuscitation manikins. Towards the development of this baseline, this document includes compilation of available scientific evidence from technical literature, international publications, expert reviews, and an industry survey which was conducted by WHO medical devices team.
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on conside...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in r...
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical gu...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge ... vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in order to make evidence-based decisions on the most appropriate control measures for each specific situation. IVM can be used for surveillance and control or for elimination of VBDs and can help reduce the development of insecticide resistance through the rational use of these products. This document provides instructions for fulfillment of the 2008 PAHO mandate set forth in CD 48/13 (Integrated Vector Management).
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring ...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the vi...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but ...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in develop...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. ...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries ... Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
This report outlines the coordination and partnership between two key ministries (Education and Public Health) in Kenya, other line ministries, the private sector, NGOs and the community in implementing the first phase ... a sub-national school-based deworming exercise. The areas targeted included Coast, Central, Western, Nyanza
and parts of Eastern provinces, covering over 45 districts in this first phase. The SBD programme is guided by the National School Health Policy and Guidelines launched in 2009.
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean,...
Suicides take a high toll. Over 800 000 people die by suicide every year and it is the second leading cause of
death in 15-29-year-olds. Most suicides occur in low- and middle-income countries where resources
and services, if they do exist, are of...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health...
This Framework offers a coherent approach for eliminating tuberculosis (TB) in low-incidence countries. It is designed to guide national policy-makers and those responsible for technical aspects of the national TB response in accelerating efforts to...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. ... plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy lives and promote well-being for all
at all ages”. It is also relevant to all the Sustainable Development Goals. Understanding the significance of the
role of health is a prerequisite for successful collective action on the social, economic and environmental
determinants of health
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence ... malaria, tuberculosis and diarrhoeal diseases.
But despite such substantial progress, the country now faces new and emerging new challenges such as the rising burden of noncommunicable diseases, increased risks associated with disasters, environmental threats and health emergencies during disease outbreaks including the COVID-19 pandemic that is a serious public health threat to Bangladesh. To establish a resilience system for future potential pandemics, the national capacity for emergency preparedness and early response to health emergencies needs to be bolstered considerably.
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design and content of the document: Billy P...
